910386-57-1 Usage
Uses
Used in Organic Synthesis:
2-(3-bromopyridin-2-yl)ethanamine is used as a building block in organic synthesis for constructing more complex organic molecules. Its unique structure allows for versatile chemical reactions, making it a valuable component in creating a wide range of compounds.
Used in Pharmaceutical Research and Development:
In the pharmaceutical industry, 2-(3-bromopyridin-2-yl)ethanamine is utilized for research and development purposes. Its potential biological activity and ability to form complex molecules make it a promising candidate for the creation of new drugs and therapeutic agents.
Used in Agrochemical Production:
2-(3-bromopyridin-2-yl)ethanamine also finds application in the production of agrochemicals. Its chemical properties can be harnessed to develop compounds that are effective in agricultural settings, such as pesticides or herbicides.
Used as a Precursor for Bioactive Compounds:
Due to its potential biological activity, 2-(3-bromopyridin-2-yl)ethanamine can be used as a precursor for the synthesis of various bioactive compounds. This allows for the development of new substances with specific biological functions, which can be applied in different fields, such as medicine or biotechnology.
Check Digit Verification of cas no
The CAS Registry Mumber 910386-57-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,0,3,8 and 6 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 910386-57:
(8*9)+(7*1)+(6*0)+(5*3)+(4*8)+(3*6)+(2*5)+(1*7)=161
161 % 10 = 1
So 910386-57-1 is a valid CAS Registry Number.
910386-57-1Relevant academic research and scientific papers
Phenethyl nicotinamides, a novel class of NaV1.7 channel blockers: Structure and activity relationship
Kers, Inger,MacSari, Istvan,Csjernyik, Gabor,Nyloef, Martin,Skogholm, Karin,Sandberg, Lars,Minidis, Alexander,Bueters, Tjerk,Malmborg, Jonas,Eriksson, Anders B.,Lund, Per-Eric,Venyike, Elisabet,Luo, Lei,Nystroem, Jan-Erik,Besidski, Yevgeni
, p. 6108 - 6115 (2012/10/30)
The NaV1.7 ion channel is an attractive target for development of potential analgesic drugs based on strong genetic links between mutations in the gene coding for the channel protein and inheritable pain conditions. The (S)-N-chroman-3-ylcarboxamide series, exemplified by 1, was used as a starting point for development of new channel blockers, resulting in the phenethyl nicotinamide series. The structure and activity relationship for this series was established and the metabolic issues of early analogues were addressed by appropriate substitutions. Compound 33 displayed acceptable overall in vitro properties and in vivo rat PK profile.
